Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, 60 y 120, (1900) La Plata, Argentina.
J Mol Cell Cardiol. 2010 Jun;48(6):1298-306. doi: 10.1016/j.yjmcc.2009.12.015. Epub 2010 Jan 6.
Ca(2+)-calmodulin-dependent protein kinase II (CaMKII) plays an important role mediating apoptosis/necrosis during ischemia-reperfusion (IR). We explored the mechanisms of this deleterious effect. Langendorff perfused rat and transgenic mice hearts with CaMKII inhibition targeted to sarcoplasmic reticulum (SR-AIP) were subjected to global IR. The onset of reperfusion increased the phosphorylation of Thr(17) site of phospholamban, without changes in total protein, consistent with an increase in CaMKII activity. Instead, there was a proportional decrease in the phosphorylation of Ser2815 site of ryanodine receptors (RyR2) and the amount of RyR2 at the onset of reperfusion, i.e. the ratio Ser2815/RyR2 did not change. Inhibition of the reverse Na(+)/Ca(2+)exchanger (NCX) mode (KBR7943) diminished phospholamban phosphorylation, reduced apoptosis/necrosis and enhanced mechanical recovery. CaMKII-inhibition (KN-93), significantly decreased phospholamban phosphorylation, infarct area, lactate dehydrogenase release (LDH) (necrosis), TUNEL positive nuclei, caspase-3 activity, Bax/Bcl-2 ratio and Ca(2+)-induced mitochondrial swelling (apoptosis), and increased contractile recovery when compared with non-treated IR hearts or IR hearts pretreated with the inactive analog, KN-92. Blocking SR Ca(2+) loading and release (thapsigargin/dantrolene), mitochondrial Ca(2+) uniporter (ruthenium red/RU360), or mitochondrial permeability transition pore (cyclosporine A), significantly decreased infarct size, LDH release and apoptosis. SR-AIP hearts failed to show an increase in the phosphorylation of Thr(17) of phospholamban at the onset of reflow and exhibited a significant decrease in infarct size, apoptosis and necrosis respect to controls. The results reveal an apoptotic-necrotic pathway mediated by CaMKII-dependent phosphorylations at the SR, which involves the reverse NCX mode and the mitochondria as trigger and end effectors, respectively, of the cascade.
钙调蛋白依赖性蛋白激酶 II(CaMKII)在介导缺血再灌注(IR)期间的细胞凋亡/坏死中起着重要作用。我们探索了这种有害影响的机制。使用靶向肌浆网(SR)的 CaMKII 抑制物(SR-AIP)对 Langendorff 灌注的大鼠和转基因小鼠心脏进行了整体 IR。再灌注开始时,磷酸化酶磷酸化酶 Thr(17)位点增加,总蛋白无变化,提示 CaMKII 活性增加。相反,肌浆网钙释放通道(RyR2)Ser2815 位点的磷酸化以及再灌注开始时 RyR2 的量呈比例下降,即 Ser2815/RyR2 比值不变。抑制反向 Na+/Ca2+交换器(NCX)模式(KBR7943)可减少磷酸化酶磷酸化,减少细胞凋亡/坏死并增强机械恢复。CaMKII 抑制(KN-93)可显著降低磷酸化酶磷酸化、梗死面积、乳酸脱氢酶释放(LDH)(坏死)、TUNEL 阳性核、半胱天冬酶-3 活性、Bax/Bcl-2 比值和 Ca2+诱导的线粒体肿胀(凋亡),与未经处理的 IR 心脏或用非活性类似物 KN-92 预处理的 IR 心脏相比,收缩恢复增加。阻断肌浆网 Ca2+摄取和释放(他帕吉丁/丹曲林)、线粒体 Ca2+单向转运体(钌红/RU360)或线粒体通透性转换孔(环孢素 A)可显著减少梗死面积、LDH 释放和凋亡。SR-AIP 心脏在再灌注开始时没有增加磷酸化酶 Thr(17)的磷酸化,并且与对照相比,梗死面积、凋亡和坏死明显减少。结果揭示了一种由 CaMKII 依赖性 SR 磷酸化介导的凋亡-坏死途径,该途径涉及反向 NCX 模式和线粒体,分别作为级联的触发和终效器。